Rabbit Recombinant Monoclonal p40-phox antibody. Suitable for IP, WB, IHC-P, ICC/IF, Flow Cyt (Intra) and reacts with Human samples. Cited in 8 publications.
View Alternative Names
SH3PXD4, NCF4, Neutrophil cytosol factor 4, NCF-4, Neutrophil NADPH oxidase factor 4, SH3 and PX domain-containing protein 4, p40-phox, p40phox
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-p40-phox antibody [EP2142Y] (AB76158)
ab76158 at 1/100-1/250 dilution staining p40-phox in human spleen by Immunohistochemistry Paraffin-embedded tissue.
- ICC/IF
Unknown
Immunocytochemistry/ Immunofluorescence - Anti-p40-phox antibody [EP2142Y] (AB76158)
ICC/IF image of ab76158 stained MCF7 cells. The cells were 4% formaldehyde fixed (10 min) and then incubated in 1%BSA / 10% normal goat serum / 0.3M glycine in 0.1% PBS-Tween for 1h to permeabilise the cells and block non-specific protein-protein interactions. The cells were then incubated with the antibody (ab76158 1/25 dilution) overnight at +4°C. The secondary antibody (green) was ab96899 DyLight® 488 goat anti-rabbit IgG (H+L) used at a 1/250 dilution for 1h. Alexa Fluor® 594 WGA was used to label plasma membranes (red) at a 1/200 dilution for 1h. DAPI was used to stain the cell nuclei (blue) at a concentration of 1.43μM.
- Flow Cyt (Intra)
Unknown
Flow Cytometry (Intracellular) - Anti-p40-phox antibody [EP2142Y] (AB76158)
Overlay histogram showing K562 cells stained with ab76158 (red line). The cells were fixed with 80% methanol (5 min) and then permeabilized with 0.1% PBS-Tween for 20 min. The cells were then incubated in 1x PBS / 10% normal goat serum / 0.3M glycine to block non-specific protein-protein interactions followed by the antibody (ab76158 1/100 dilution) for 30 min at 22°C. The secondary antibody used was DyLight® 488 goat anti-rabbit IgG (H+L) (ab96899) at 1/500 dilution for 30 min at 22°C. Isotype control antibody (black line) was rabbit IgG (monoclonal) (1μg/1x106 cells) used under the same conditions. Acquisition of >5000 events was performed.
- IP
Lab
Immunoprecipitation - Anti-p40-phox antibody [EP2142Y] (AB76158)
p40-phox was immunoprecipitated from 0.35 mg HL-60 (Human acute promyelocytic leukemia promyeloblast) whole cell lysate 10 μg with ab76158 at 1/50 dilution (2μg). VeriBlot for IP Detection Reagent (HRP) (ab131366) was used at 1/5000 dilution.
Lane 1 : HL-60 (Human acute promyelocytic leukemia promyeloblast) whole cell lysate 10 μg
Lane 2 : ab76158 IP in HL-60 whole cell lysate
Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab76158 in HL-60 whole cell lysate
Blocking and dilution buffer and concentration : 5% NFDM/TBST.
All lanes:
Immunoprecipitation - Anti-p40-phox antibody [EP2142Y] (ab76158)
Predicted band size: 39 kDa
Observed band size: 39 kDa
false
- WB
Unknown
Western blot - Anti-p40-phox antibody [EP2142Y] (AB76158)
All lanes:
Western blot - Anti-p40-phox antibody [EP2142Y] (ab76158) at 1/50000 dilution
All lanes:
HL60 cell lysate at 10 µg
Secondary
All lanes:
Goat anti-rabbit HRP conjugated at 1/2000 dilution
Predicted band size: 39 kDa
Observed band size: 39 kDa
false
Related conjugates and formulations (10)
-
578 PE
PE Anti-p40-phox antibody [EP2142Y]
-
660 APC
APC Anti-p40-phox antibody [EP2142Y]
-
HRP Anti-p40-phox antibody [EP2142Y]
-
617 Alexa Fluor® 594
Alexa Fluor® 594 Anti-p40-phox antibody [EP2142Y]
-
519 Alexa Fluor® 488
Alexa Fluor® 488 Anti-p40-phox antibody [EP2142Y]
-
603 Alexa Fluor® 568
Alexa Fluor® 568 Anti-p40-phox antibody [EP2142Y]
-
565 Alexa Fluor® 555
Alexa Fluor® 555 Anti-p40-phox antibody [EP2142Y]
-
Anti-p40-phox antibody [EP2142Y] - BSA and Azide free
-
665 Alexa Fluor® 647
Alexa Fluor® 647 Anti-p40-phox antibody [EP2142Y]
-
775 Alexa Fluor® 750
Alexa Fluor® 750 Anti-p40-phox antibody [EP2142Y]
Reactivity data
Product details
Species reactivity
Mouse, Rat: We have preliminary internal testing data to indicate this antibody may not react with these species.
Please contact us for more information.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
P40-phox participates in innate immune responses by regulating the NADPH oxidase complex's function. It acts as a scaffold to facilitate the interaction between cytosolic and membrane components. p40-phox integrates into the cytosolic fraction with other subunits and translocates to the membrane upon stimulation. This translocation is essential for generating superoxide radicals that are involved in defense against pathogens. Its functional domains enable it to bind phosphatidylinositol (34) bisphosphate which anchors the protein to the membrane. p40-phox itself is not an enzyme but modulates the activity of the complex.
Pathways
The p40 protein serves as an important player in the signaling cascade of the respiratory burst. It interacts with the phosphoinositide 3-kinase (PI3K) pathway and cooperates with other proteins like p67-phox and p47-phox through phosphorylation-dependent mechanisms. The p40-phox is phox compatible meaning it can integrate into various signaling modules. Within the oxidative burst pathway it enhances the cytosolic complex's attachment to the membrane affecting the production of ROS.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (8)
Recent publications for all applications. Explore the full list and refine your search
Nature microbiology 9:2970-2984 PubMed39242815
2024
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 15:5170 PubMed38886341
2024
Applications
Unspecified application
Species
Unspecified reactive species
Annals of medicine and surgery (2012) 86:2644-2650 PubMed38694326
2024
Applications
Unspecified application
Species
Unspecified reactive species
Methods in molecular biology (Clifton, N.J.) 1982:543-571 PubMed31172495
2019
Applications
Unspecified application
Species
Unspecified reactive species
Molecular therapy : the journal of the American Society of Gene Therapy 23:147-57 PubMed25288370
2014
Applications
Unspecified application
Species
Unspecified reactive species
The Journal of biological chemistry 287:12395-404 PubMed22235113
2012
Applications
WB, ICC/IF
Species
Human, Human
The Journal of biological chemistry 286:40693-705 PubMed21956105
2011
Applications
Unspecified application
Species
Unspecified reactive species
Journal of leukocyte biology 88:791-805 PubMed20610796
2010
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com